AU2007302663B2 - Azithromycin for the treatment of nodular acne - Google Patents

Azithromycin for the treatment of nodular acne Download PDF

Info

Publication number
AU2007302663B2
AU2007302663B2 AU2007302663A AU2007302663A AU2007302663B2 AU 2007302663 B2 AU2007302663 B2 AU 2007302663B2 AU 2007302663 A AU2007302663 A AU 2007302663A AU 2007302663 A AU2007302663 A AU 2007302663A AU 2007302663 B2 AU2007302663 B2 AU 2007302663B2
Authority
AU
Australia
Prior art keywords
azithromycin
acne
treatment
administered
nodules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2007302663A
Other languages
English (en)
Other versions
AU2007302663A1 (en
Inventor
Barry Calvarese
Bhaskar Chaudhuri
Gordon Jay Dow
David Wade Osborne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Pharmaceutical Sciences Inc
Original Assignee
Dow Pharmaceutical Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Pharmaceutical Sciences Inc filed Critical Dow Pharmaceutical Sciences Inc
Publication of AU2007302663A1 publication Critical patent/AU2007302663A1/en
Application granted granted Critical
Publication of AU2007302663B2 publication Critical patent/AU2007302663B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
AU2007302663A 2006-10-03 2007-09-24 Azithromycin for the treatment of nodular acne Ceased AU2007302663B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US84906506P 2006-10-03 2006-10-03
US60/849,065 2006-10-03
US11/635,127 2006-12-06
US11/635,127 US7704959B2 (en) 2006-10-03 2006-12-06 Azithromycin for the treatment of nodular acne
PCT/US2007/020583 WO2008042139A2 (en) 2006-10-03 2007-09-24 Azithromycin for the treatment of nodular acne

Publications (2)

Publication Number Publication Date
AU2007302663A1 AU2007302663A1 (en) 2008-04-10
AU2007302663B2 true AU2007302663B2 (en) 2012-07-12

Family

ID=39261797

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007302663A Ceased AU2007302663B2 (en) 2006-10-03 2007-09-24 Azithromycin for the treatment of nodular acne

Country Status (18)

Country Link
US (2) US7704959B2 (enExample)
EP (2) EP2086552B1 (enExample)
JP (1) JP2010505827A (enExample)
KR (1) KR20090064592A (enExample)
CN (2) CN102614210A (enExample)
AT (1) ATE533496T1 (enExample)
AU (1) AU2007302663B2 (enExample)
BR (1) BRPI0719535A2 (enExample)
CA (1) CA2664673A1 (enExample)
CY (1) CY1112650T1 (enExample)
DK (1) DK2086552T3 (enExample)
ES (2) ES2574677T3 (enExample)
MX (1) MX2009003484A (enExample)
PL (2) PL2086552T3 (enExample)
PT (1) PT2086552E (enExample)
RU (1) RU2009116629A (enExample)
SI (1) SI2086552T1 (enExample)
WO (1) WO2008042139A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8143227B2 (en) * 2007-09-05 2012-03-27 Dow Pharmaceutical Sciences, Inc. Azithromycin for treatment of skin disorders
US8124123B2 (en) * 2007-09-05 2012-02-28 Dow Pharmaceutical Sciences, Inc. Controlled release azithromycin solid dosages forms
CN107281155B (zh) * 2017-06-06 2020-04-10 扬子江药业集团四川海蓉药业有限公司 一种阿奇霉素片及其制备方法
CA3070663A1 (en) * 2017-07-21 2019-01-24 Almirall, Llc Treatment of non-inflammatory lesions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474758A (en) 1981-11-19 1984-10-02 American Cyanamid Company Haemophilus influenzae type b and pertussis outer membrane component combined vaccine
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4474766A (en) 1983-06-27 1984-10-02 Merck & Co., Inc. Anti-inflammatory/analgesic combination of cyclo-(N-methyl-Ala-Tyr-D-Trp-Lys-Val-Phe) and a selected non-steroidal anti-inflammatory drug (NSAID)
MX12213A (es) 1987-07-09 1993-05-01 Pfizer Metodo de preparacion de dihidrato de azitromicina cristalino
FR2710841B1 (fr) * 1993-10-05 1995-11-17 Oreal Composition cosmétique ou pharmaceutique pour la peau, anhydre et stable, à base de rétinol et son utilisation en vue du traitement des maladies de la peau.
GB9723669D0 (en) * 1997-11-07 1998-01-07 Univ Aberdeen Skin penetration enhancing components
US7211267B2 (en) 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
EP1716856A3 (en) * 2001-04-05 2009-02-18 Collagenex Pharmaceuticals, Inc. The treatment of acne
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
US9035741B2 (en) * 2003-06-27 2015-05-19 Stryker Corporation Foot-operated control console for wirelessly controlling medical devices

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
INNOCENZI et al. Dermatologica Clinica (2005) vol. 25, no. 3, pages 126-130 *
RAFIEI et al. Journal of Dermatological Treatment (2006) vol. 17, no. 4, pages 217-221 *

Also Published As

Publication number Publication date
ES2377470T3 (es) 2012-03-27
US7704959B2 (en) 2010-04-27
RU2009116629A (ru) 2010-11-10
MX2009003484A (es) 2009-10-26
PT2086552E (pt) 2011-12-19
SI2086552T1 (sl) 2012-01-31
EP2420240A1 (en) 2012-02-22
PL2420240T3 (pl) 2016-10-31
ES2574677T3 (es) 2016-06-21
CN101534837A (zh) 2009-09-16
JP2010505827A (ja) 2010-02-25
US20100216732A1 (en) 2010-08-26
WO2008042139A3 (en) 2008-10-16
CN101534837B (zh) 2012-04-04
EP2086552B1 (en) 2011-11-16
DK2086552T3 (da) 2012-01-09
CN102614210A (zh) 2012-08-01
BRPI0719535A2 (pt) 2014-01-14
CA2664673A1 (en) 2008-04-10
KR20090064592A (ko) 2009-06-19
EP2420240B1 (en) 2016-05-11
CY1112650T1 (el) 2016-02-10
WO2008042139A2 (en) 2008-04-10
PL2086552T3 (pl) 2012-03-30
ATE533496T1 (de) 2011-12-15
HK1130667A1 (en) 2010-01-08
US20080081790A1 (en) 2008-04-03
AU2007302663A1 (en) 2008-04-10
EP2086552A4 (en) 2009-11-04
EP2086552A2 (en) 2009-08-12

Similar Documents

Publication Publication Date Title
Goulden Guidelines for the management of acne vulgaris in adolescents
RU2413509C2 (ru) Способ применения адапалена при поддерживающей терапии угревой сыпи
US9132139B2 (en) Maintenance therapy regime/regimen for the treatment of acne
MX2010012385A (es) Regimen de terapia para tratar enfermedades relacionadas al acne.
Basak et al. Acne and its management
Strauss et al. Concomitant administration of vitamin E does not change the side effects of isotretinoin as used in acne vulgaris: a randomized trial
EP2420240B1 (en) Azithromycin for the treatment of nodular acne
US20140336257A1 (en) Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris
JP2019524767A (ja) ９−アミノメチルミノサイクリン化合物及びその使用
US20050158404A1 (en) Composition and method for treatment of acne
Yeo et al. Treatment of acne in children
HK1162921A (en) Azithromycin for the treatment of nodular acne
Alyasi et al. Isotretinoin-induced thrombocytosis in a patient with acne vulgaris: a case report
HK1130667B (en) Azithromycin for the treatment of nodular acne
Uddin et al. Comparative Evaluation of Azithromycin and Doxycycline in the Management of Acne Vulgaris–A Study of 120 Cases
Chim Acne vulgaris
KR20250091323A (ko) 국소 댑손 조성물을 사용하는 심상성 여드름의 치료 방법
EP1845965A1 (en) Adapalene for the long-term treatment of acne vulgaris
TUCKER New Acne Recommendations Stress Combo Tx

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired